Reflecting the known proliferative effect of E2 in breast cancer cells and confirming the activation of proliferative pathways in this cell line model, the PCNA index of E2-treated cells was highest (Fig. 5a, where DOX treatment alone, which is used to induce MR, is equivalent to vehicle treatment). Here, PCNA is linked to breast carcinoma.